ClinicalTrials.Veeva

Menu

A Trial Comparing Single Intra-op Dose of Methadone Versus Placebo in Patients Undergoing Spine Surgery

Baylor College of Medicine logo

Baylor College of Medicine

Status and phase

Completed
Phase 4

Conditions

Thoracolumbar Scoliosis

Treatments

Drug: Methadone
Drug: Normal Saline

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Scoliosis is a disease that involves lateral and/or rotational deformity of the spine and can affect up to 4% of the population. Typically, surgery is considered when Cobb's angle, which is a measurement used for evaluation of curves in scoliosis on an anterior-posterior radiographic projection of the spine, is greater than 50 degrees in the thoracic region (40 degrees in the lumbar region) or when the curvature causes significant pain, or respiratory and cardiovascular restriction. Patient undergoing this surgical correction experience severe pain in the postoperative period and the management includes the use of opioid-based patient-controlled analgesia (PCA).

Full description

Scoliosis is a disease that involves lateral and/or rotational deformity of the spine and can affect up to 4% of the population. Typically, surgery is considered when Cobb's angle, which is a measurement used for evaluation of curves in scoliosis on an anterior-posterior radiographic projection of the spine, is greater than 50 degrees in the thoracic region (40 degrees in the lumbar region) or when the curvature causes significant pain, or respiratory and cardiovascular restriction. Patient undergoing this surgical correction experience severe pain in the postoperative period and the management includes the use of opioid-based patient-controlled analgesia (PCA).

Methadone is an opioid with one of the longest elimination half-life and has been used as an effective analgesic for acute, chronic, neuropathic, and cancer pain in adults, children, and even neonates1-5. Its long duration of action and antagonism to the N-methyl-d-aspartate receptor may decrease the need for PCA use in the postoperative period. Gourlay2 demonstrated the effectiveness and utility of perioperative methadone including the advantages of longer analgesia with no serious side effects of respiratory depression. A recent study by Gottschalk2 in adult patients demonstrated a 50% reduction of postoperative opioids at 48 hours and lower pain scores after a single bolus of methadone before surgical incision. However, a major weakness of the study is that patients did not receive equipotent intraoperative opioids. In addition, the adolescent patient population will undergo a much larger surgical incision with potential for greater postoperative pain. Despite this potential benefit, methadone is seldom used in the perioperative setting. A more recent pharmacokinetic study of methadone in adolescents undergoing spine surgery failed to show a reduction in opioid consumption as it was powered to determine pharmacokinetics and not a secondary endpoint of postoperative opioid consumption. An appropriately powered study is still required to determine the efficacy of methadone in reducing postoperative pain after spine surgery.

Enrollment

74 patients

Sex

All

Ages

10 to 17 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patient age 10 - 17 years
  2. Patients undergoing multilevel thoraco-lumbar spine surgery with instrumentation and fusion

Exclusion criteria

  1. Preoperative methadone therapy
  2. Inability to use the PCA
  3. Allergy to methadone or morphine
  4. Morbid obesity with a body mass index >36.0 kg/m2
  5. Patients with chronic renal failure defined by serum creatinine >2.0 mg/dL
  6. Liver failure defined as a history of cirrhosis or fulminant hepatic failure
  7. Preoperative congenital heart disease or arrhythmias
  8. Patient refusal to participate in study
  9. Pregnancy (It is standard of care for all post menarche female patients to undergo a urine pregnancy test prior to surgery).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

74 participants in 2 patient groups, including a placebo group

Treatment group
Active Comparator group
Description:
The treatment group will receive 0.2 mg/kg methadone diluted to a 20 ml infusion over 10 minutes.
Treatment:
Drug: Methadone
Control Group
Placebo Comparator group
Description:
The control group will receive a 20 ml normal saline placebo infusion over 10 minutes
Treatment:
Drug: Normal Saline

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems